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Abstract
Introduction: The function of Glycogen Synthase Kinases 3b (GSK-3b) has previously been shown to be necessary for normal
secondary palate development. Using GSK-3ß null mouse embryos, we examine the potential coordinate roles of Wnt and
Hedgehog signaling on palatal ossification.
Methods: Palates were harvested from GSK-3b, embryonic days 15.0–18.5 (e15.0–e18.5), and e15.5 Indian Hedgehog (Ihh)
null embryos, and their wild-type littermates. The phenotype of GSK-3b null embryos was analyzed with skeletal whole
mount and pentachrome stains. Spatiotemporal regulation of osteogenic gene expression, in addition to Wnt and Hedgehog
signaling activity, were examined in vivo on GSK-3b and Ihh +/+ and 2/2 e15.5 embryos using in situ hybridization and
immunohistochemistry. To corroborate these results, expression of the same molecular targets were assessed by qRT-PCR of
e15.5 palates, or e13.5 palate cultures treated with both Wnt and Hedgehog agonists and anatagonists.
Results: GSK-3b null embryos displayed a 48 percent decrease (*p,0.05) in palatine bone formation compared to wild-type
littermates. GSK-3b null embryos also exhibited decreased osteogenic gene expression that was associated with increased
Wnt and decreased Hedgehog signaling. e13.5 palate culture studies demonstrated that Wnt signaling negatively regulates
both osteogenic gene expression and Hedgehog signaling activity, while inhibition of Wnt signaling augments both
osteogenic gene expression and Hedgehog signaling activity. In addition, no differences in Wnt signaling activity were noted
in Ihh null embryos, suggesting that canonical Wnt may be upstream of Hedgehog in secondary palate development. Lastly,
we found that GSK-3b 2/2 palate cultures were ‘‘rescued’’ with the Wnt inhibitor, Dkk-1.
Conclusions: Here, we identify a critical role for GSK-3b in palatogenesis through its direct regulation of canonical Wnt
signaling. These findings shed light on critical developmental pathways involved in palatogenesis and may lead to novel
molecular targets to prevent cleft palate formation.
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Introduction
Craniofacial birth defects, such as cleft lip and/or palate, can
cause extensive physical and psychosocial complications, repre-
senting a significant socioeconomic burden. Multiple operations
are often required to surgically reconstruct the palate defect, and
affected children continue to suffer from complications with
speech, feeding, dentition, hearing, and other craniofacial growth
deficiencies. Although several genes have been associated with a
small percentage of cleft palate defects, the etiology of the majority
of cases remains elusive.
The function of Glycogen Synthases Kinase-3b (GSK-3b) has
previously been shown to be critical for normal craniofacial
development [1]. GSK-3ß is a key integrator of various molecular
pathways and thus functions as an essential component for normal
development. For instance, deletion of both GSK-3 isoforms
(designated a and b), which differ primarily in their N-terminal
domains, results in early embryonic lethality [2]. As a kinase,
GSK-3ß acts to inhibit rather than activate its substrate.
Therefore, inactivation of GSK-3ß typically results in the release
of its inhibition on the specific pathways it regulates, resulting in an
upregulation of signaling activity in these pathways. GSK-3ß is an
important regulator of a number of molecular pathways, such as
Wnt, Hedgehog, NFAT, and insulin signaling [1]. Of these pathways,
the precise regulation of both Wnt and Hedgehog signaling may be
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either of these pathways can lead to craniofacial abnormalities,
including palatal clefting [3,4,5].
In mice, secondary palate development begins on embryonic
day 12.5 (e12.5). At this time, the maxillary processes give rise to
bilateral palatal shelves, consisting of a mesodermal core that is
surrounded by neural crest cells in addition to pharyngeal
endoderm and ectoderm [6]. By e15.5, palatal fusion is complete
and mesenchymal condensation occurs, followed by the osteogenic
differentiation of the palatal mesenchyme, leading to the formation
of the palatine bone in the secondary palate [6]. It has been shown
that both Wnt and Hedgehog pathways play central roles in the
differentiation of mesenchymal progenitor cells down an osteo-
blastic lineage [7,8,9,10,11]. More importantly, both higher levels
of Wnt and lower levels of Hedgehog signaling have been shown to
inhibit osteogenic differentiation of mesenchymal cells
[11,12,13,14], indicating that pathways capable of inhibiting Wnt
(such as GSK3ß) and stimulating Hedgehog may play an important
role in bone formation.
In light of the fact that both Wnt and Hedgehog signaling have
previously been shown to be regulated by GSK-3ß, and implicated
in normal craniofacial development and mesenchymal osteogen-
esis, we set out to examine the potential coordinate roles of Wnt
and Hedgehog signaling on the ossification program of the palatine
bones in the developing secondary palate. More specifically, we
hypothesize that the loss of GSK-3ß leads to a diminutive palatine
bone and impaired palatal ossification due to alterations in both
Wnt and Hedgehog signaling. Moreover, we hypothesize that the
inactivation of GSK-3b leads to enhanced Wnt signaling, which
subsequently leads to decreases in Hedgehog signaling, and that it is
in this setting of enhanced Wnt and decreased Hedgehog signaling
that palatal ossification is compromised.
Results
GSK-3b Null Embryos Display Diminutive Palatine Bones
in the Developing Secondary Palate
We have previously shown that GSK-3b null embryos display
complete clefting of the secondary palate. In order to more
thoroughly analyze the GSK-3b null embryo palatal phenotype, we
performed a whole mount skeletal stain looking specifically at the
palatine bones (Figure 1), as the palatine processes of the maxilla
and the horizontal lamina of the palatine bones form the
secondary palate, which is clefted in the GSK-3b null embryo.
Based on alizarin red staining of the secondary palate, the palatine
bones are appreciably smaller in the GSK-3b null embryos when
compared to controls (Figure 1A). Next, we quantified the area of
the palatine bones, which were significantly decreased in the GSK-
3b 2/2 embryos when compared to controls at both e17.0 and
e18.5 (Figure 1B). More specifically, when compared to wild-type
littermates, the area of the palatine bones displayed a 48 percent
decrease in the GSK-3b null embryos at both e17.0 and e18.5
(Figure 1B). These data clearly show that the area of the palatine
bones in the developing palate of the GSK-3b null embryo remain
consistently and significantly smaller in size than their wild-type
littermates.
GSK-3b Null Embryos Exhibit Inhibited Ossification of the
Palatine Bones in the Developing Secondary Palate
Next, we analyzed the histology of the developing palate in
order to confirm that GSK-3b null embryos exhibit inhibited
ossification of the palatine bones. Since palatine bone formation
begins at approximately e14.5 in mice [6], we performed a
pentachrome stain on e15.0 and e15.5 embryos. At e15.0, traces of
bone (yellow staining) were present in the GSK-3b +/+ embryos,
while no bone (only blue staining) was appreciated in the GSK-3b
2/2 embryos (Figure 2, first row). At e15.5, the developing
palatine bone in GSK-3b +/+ embryos was largely composed of
bone (yellow staining), while no bone (only blue staining) was
noted in GSK-3b 2/2 embryos (Figure 2, second row). These
data indicate that ossification of the palatine bones is inhibited in
GSK-3b 2/2 embryos.
GSK-3b 2/2 Embryos Exhibit Decreased Osteogenic
Gene Expression in the Palatine Bones
After confirmation that GSK-3b null embryos exhibit decreased
ossification of the palatine bones, we next sought to determine
whether or not this decrease correlated with a down-regulation in
osteogenic gene expression using both in situ hybridization and
qRT-PCR. In order to determine whether GSK-3b null embryos
express decreased levels of osteogenic gene markers in the
developing palate, we performed an in situ hybridization for the
specific osteogenic genes Runt-Related Transcription Factor 2 (Runx2),
Osteocalcin (Ocn), and Type 1 Collagen (Col1a1) on coronal sections of
e15.5 GSK-3b +/+ and 2/2 embryos. The embryonic age of
e15.5 was chosen as this is the time point at which osteogenic gene
markers reach peak expression levels [13]. Additionally, e15.5 is
when we begin to appreciate the palatine bone on histology. Not
surprisingly, we observed a substantial decrease in both the
domain and intensity of signal for Runx2, Ocn, and Col1a1
transcripts in the area of the developing palatine bone
(Figure 3A–C), indicating that GSK-3b null embryos exhibit
decreased palatal osteogenic gene expression, leading to decreased
ossification in the palatine bone and hard palate.
In order to further corroborate our findings from in situ
hybridization, qRT-PCR was performed on palates dissected from
GSK-3b +/+ and 2/2 embryos at e15.5. A significant decrease in
the osteogenic gene markers Alkaline Phosphatase (Alp), Runx2, Ocn,
and Col1a1 was observed by qRT-PCR in GSK-3b 2/2 embryos
when compared to their wild-type littermates (Figure 3D). Taken
together, these data indicate that GSK-3b 2/2 embryos have
decreased osteogenic gene expression in the palatine bone of the
developing palate, when compared to GSK-3b +/+ embryos.
After confirmation that GSK-3b null embryos exhibit decreases
in osteogenic gene expression, we next sought to determine which
signaling pathways were responsible. We assessed both Wnt and
Hedgehog signaling pathways in the GSK-3b null embryo as both
pathways are regulated by GSK-3b [1] and implicated in
craniofacial development [3,4,5], in addition to mesenchymal
ossification [11,12,13].
GSK-3b Null Mutant Embryos Exhibit Increased Wnt
Signaling in the Developing Palate
We compared canonical Wnt signaling between e15.5 GSK-3b
+/+ and 2/2 embryos by assessing protein immunoreactivity of
both a key mediator of the canonical Wnt signaling pathway, b-
catenin, and a direct target of the canonical Wnt signaling
pathway, Axin-2 [15]. When cells are not exposed to a Wnt signal,
the level of cytosolic b-catenin, in both its active and inactive
forms, is kept low through its association with a protein complex,
including the protein kinase, GSK-3b. GSK-3b phosphorylates b-
catenin, leading to its degradation through the ubiquitin pathway.
When cells are exposed to a Wnt signal, a conformation change in
the GSK-3b protein complex makes GSK-3b unable to phos-
phorylate b-catenin. The unphosphorylated, active, b-catenin is
translocated into the nucleus, which leads to the transcription of
downstream Wnt target genes [16,17]. Therefore, cells with
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catenin immunostaining. In addition, we also assessed protein
immunoreactivity of a direct target of the canonical Wnt signaling
pathway, Axin-2 [15]. As shown, GSK-3b 2/2 embryos exhibited
a slightly more intense total b-catenin immunostaining compared
to controls (Figure 4A, second column). More importantly,
GSK-3b 2/2 embryos displayed increased protein immunostain-
ing of both active b-catenin and Axin-2 in the palatine bone by
immunohistochemistry compared to wild-type littermates
(Figure 4A, third and fourth columns). Quantification of
DAB-positive nuclei per high power field displayed significantly
greater active b-catenin positive nuclei in the GSK-3b 2/2 palates
compared to controls (Figure 4B). Additionally, several canonical
Wnt ligand genes are expressed in the craniofacial region,
including Wnt 3 and Wnt 9b [18]. Therefore, we performed an
in situ hybridization for Wnt 9b to provide a more complete picture
of how deletion of GSK-3b impacts Wnt signaling. We found that
the intensity and distribution of Wnt9b transcripts was greater in
the GSK-3b null embryo compared to wild-type, suggesting that
increased Wnt signaling results in an upregulation of Wnt 9b in the
craniofacial region (Figure 4C). After confirmation that GSK-3b
null embryos exhibit increased Wnt signaling, we decided to next
evaluate Hedgehog signaling.
GSK-3b Null Embryos Display Decreased Hedgehog
Signaling in the Developing Palate
Both Wnt and Hedgehog signaling pathways are regulated by
GSK-3b [1] and implicated in craniofacial development [3,4,5], in
addition to mesenchymal ossification [11,12,13]. Since Wnt
signaling activity is enhanced in the GSK-3b null embryo, we
wanted to determine whether Hedgehog signaling was also affected.
Therefore, we next investigated whether a difference in Hedgehog
signaling existed between GSK-3b +/+ and 2/2 embryos.
In order to assess Hedgehog signaling in vivo, we performed both in
situ hybridization and immunohistochemistry on e15.5 GSK-3b +/+
and 2/2 embryos for different markers of Hedgehog activity
Figure 1. GSK-3b 2/2 palatal phenotype. (A) Bone and cartilage whole mount staining of GSK-3b +/+ (left) and GSK-3b 2/2 (right) embryos at
e17.0 (first row) and e18.5 (second row). In this stain, bone appears red and cartilage appears blue. White dashed lines indicate the location of the
palatine bones (pb), for emphasis. The basisphenoid bone (bs) is labeled for orientation purposes. Scale bars represent 600 mm. (B) The area of the
palatine bones was quantified at both e17.0 and e18.5 using Adobe Photoshop, as the number of pixels per 46field. The area of the palatine bones
displayed a 48 percent decrease in the GSK-3b null embryos at both e17.0 and e18.5. N=3, *p,0.05.
doi:10.1371/journal.pone.0025847.g001
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shownthatHedgehogsignalinginthe developingpalatepeaksate15.5
[13]. An Ihh and Ptch1 in situ hybridization exhibited decreased
transcripts in GSK-3b null embryos when compared to their wild-
type littermates (Figure 5A,B). Additionally, immunohistochemis-
try was performed, demonstrating that GSK-3b null embryos also
displayed decreased Ptch1 and Gli1 protein immunoreactivity when
compared to controls (Figure 5C,D).
In order to further corroborate our findings from in situ
hybridization and immunohistochemistry, qRT-PCR was per-
formed on e15.5 embryos. GSK-3b 2/2 embryos exhibited a
significant decrease in expression of the Hedgehog ligands, Indian
Hedgehog (Ihh) and Sonic Hedgehog (Shh), the Hedgehog receptor,
Patched Homolog 1 (Ptch1), and the Hedgehog downstream target, GLI-
Kruppel family member GLI1 (Gli 1) by qRT-PCR when compared to
controls (Figure 5E). Taken together, these data indicate that
Hedgehog signaling activity is decreased in the palatine bone of GSK-
3b 2/2 embryos when compared to their wild-type littermates.
Now that we had confirmed that GSK-3b 2/2 mice exhibit
aberrant Wnt and Hedgehog signaling, we next sought to determine
which of these pathways accounted for the impaired palatal
ossification found in GSK-3b null embryos.
Upregulation of the Wnt Signaling Pathway Leads to
Decreased Osteogenesis In Vitro
In order to determine whether enhanced canonical Wnt
signaling alone could lead to a decrease in palatal osteogenesis,
wild-type, CD-1 palate cultures were established at e13.5 and
treated with DMEM F12 or DMEM F12 supplemented with
Wnt3A (100 ng/mL). This time point was chosen as previous
studies have demonstrated that GSK-3b 2/2 palates can be
‘‘rescued’’ in vivo by restoring endogenous GSK-3b levels between
e13.5 and e15.0 [1]. Viability of cells after 4 days in culture using
this palate culture technique has previously been demonstrated
with IVIS technology [13]. After palate cultures were established,
qRT-PCR was performed after 2 days to investigate both
osteogenic gene expression and Hedgehog signaling in Wnt3A-
treated palate cultures (Figure 6A–B). After 2 days in culture, a
significant decrease was noted in the ostegenic gene markers Alp,
Runx2, Ocn, and Col1a1 in Wnt3A-treated palates when compared
to controls (Figure 6A). Since Wnt3A treatment alone led to a
significant decrease in palatal osteogenesis, we wanted to
determine whether increased Wnt signaling also affected the
Hedgehog signaling pathway.
Upregulation of the Wnt Signaling Pathway Leads to
Decreased Hedgehog Signaling Activity In Vitro
Palate cultures treated with Wnt3A led to a significant decrease
in Hedgehog ligands, Ihh and Shh, and the downstream target, Gli1
by qRT-PCR after 2 days in culture (Figure 6B). These data
confirm that an increase in canonical Wnt signaling results in
decreases of both osteogenic gene markers and Hedgehog signaling
activity and is therefore sufficient to mimic the gene expression
pattern found in GSK-3b null embryo palates.
Inhibition of the Wnt Signaling Pathway Leads to
Increased Osteogenesis In Vitro
Because treatment with Wnt3A led to decreased osteogenesis in
vitro, we wanted to determine whether inhibition of canonical Wnt
signaling would lead to increases in osteogenesis in the developing
palate. Therefore, wild-type, CD-1 palate cultures at e13.5 were
treated with DMEM F12 +/2 supplementation with a canonical
Wnt inhibitor, Dickkopf-related protein 1 (Dkk-1) at 100 ng/mL
for 2 days (Figure 6C). After 2 days in culture, palates treated
with Dkk-1 displayed significant increases in the osteogenic genes
Alp, Runx2, Ocn, and Col1a1 by qRT-PCR (Figure 6C).
Inhibition of Wnt Signaling Leads to Increased Hedgehog
Signaling
Because treatment with Wnt3A led to decreased Hedgehog
signalingin vitro, we also wantedto determine whether the inhibition
of Wnt signaling would lead to increased Hedgehog signaling. e13.5
Figure 2. GSK-3b null embryos exhibit inhibited ossification of the palatine bone. Pentachrome staining of e15.0 (first row) and e15.5
(second row) coronal sections from GSK-3b +/+ (left) and GSK-3b 2/2 (right) embryos. In this stain, bone appears yellow. For orientation purposes, a
low magnification image is shown in the outermost columns. A yellow box is drawn around the area seen in higher magnification in the center
columns. (First row) At e15.0, GSK-3b +/+ embryos display trace amounts of bone (yellow staining) in the developing palatine bone (pb), while no
bone is noted in GSK-3b 2/2 embryos. (Second row) At e15.5, the developing palatine bone of GSK-3b +/+ embryos is composed mostly of bone
(yellow staining), while no bone is appreciated in GSK-3b 2/2 embryos. Tongue (t), Nasal Cavity (nc), and Meckel’s Cartilage (mc) are labeled for
orientation purposes. Scale bars represent 800 mm in the low magnification, outermost columns, and 100 mm in the high magnification, center
columns.
doi:10.1371/journal.pone.0025847.g002
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supplementation with Dkk-1 (100 ng/mL) for 2 days (Figure 6D).
Wild-type palates treated with the canonical Wnt inhibitor
demonstrated significantly increased levels of Hedgehog ligands, Ihh
and Shh, and the downstream target, Gli1 (Figure 6D).
Inhibition of Hedgehog Signaling Also Leads to
Decreased Ostegenesis In vitro
Because palate cultures treated with Wnt3A led to both a
decrease in osteogenic gene markers in addition to a decrease in
Hedgehog signaling, we next wanted to determine whether the
inhibition of Hedgehog signaling with cyclopamine would also lead
to a decrease in palatal osteogenesis. Previous studies with Ihh null
embryos suggested that inhibition of Hedgehog signaling alone
results in significant decreases of osteogenic gene expression in the
developing palate [13]. Wild-type, CD-1 palate cultures were
established at e13.5 and treated with DMEM F12 +/2
supplementation with cyclopamine (20 mM) (Figure 7A). As
expected, wild-type palate cultures treated with cyclopamine for 2
days exhibited a decrease in the osteogenic gene markers Alp,
Runx2, and Col1a1 by qRT-PCR, with a significant decrease in
Col1a1 when compared to controls (Figure 7A).
Figure 3. GSK-3b 2/2 embryos exhibit decreased osteogenic gene expression in the palatine bones. (A–C) In situ hybridization for the
osteogenic genes Runx2 (A), Ocn (B), and Col1a1 (C). As shown, the intensity and distribution of osteogenic gene transcripts is greater in the GSK-3b +/
+ embryos than in the GSK-3b 2/2 embryos within and around the palatine bone (pb). The dotted lines in the first and third columns indicate the
area shown in higher magnification in the second and fourth columns, respectively. The tongue (t) and nasal cavity (nc) are labeled for orientation
purposes. Control experiments using sense probes were performed for all genes (data not shown). Scale bars in the low magnification images (first
and third columns) represent 200 mm. Scale bars in higher magnification images (second and fourth) represent 100 mm. (D) qRT-PCR of e15.5 GSK-3b
+/+ and 2/2 embryos. GSK-3b 2/2 embryos display significantly decreased levels of the osteogenic genes Alp, Runx2, Ocn, and Col1a1 by qRT-PCR,
in comparison to wild-type littermates. N=3, *p,0.01.
doi:10.1371/journal.pone.0025847.g003
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Developing Palate Results in Increased Osteogenesis In
Vitro
Because inhibition of the Hedgehog signaling pathway with
cyclopamine resulted in decreased palatal osteogenesis, we wanted
to determine whether the converse was also true. Therefore, e13.5
wild-type,CD-1 palate cultures were treated with DMEM F12 +/2
supplementation with a recombinant Hedgehog ligand, Shh-N
(250 ng/mL) for 2 days (Figure 7B). After 2 days in culture,
palates treated with Shh-N displayed significant increases in
osteogenic gene expression (Alp, Runx2,a n dCol1a1) by qRT-PCR
(Figure 7B).
Alterations in Hedgehog Signaling Results in No Obvious
Changes in Canonical Wnt Signaling
We performed immunohistochemistry and in situ hybridization
on coronal sections of e15.5 Ihh null embryos and their wild-type
littermate controls in order to evaluate canonical Wnt signaling
activity (Figure 8). No differences were noted in protein staining
of either total or active ß-catenin, or Axin-2, a direct target of the
canonical Wnt signaling pathway (Figure 8A). In addition,
quantification of DAB-positive nuclei per high power field
displayed no significant differences in active b-catenin immuno-
staining between Ihh +/+ and 2/2 palates (Figure 8B).
Similarly, no differences were noted in the canonical Wnt ligand,
Wnt 9b, which is normally expressed in the craniofacial region [18]
(Figure 8C). While alterations in canonical Wnt signaling affected
Hedgehog signaling, alterations in the Hedgehog pathway did not
appear to affect the Wnt pathway. These data suggest that
canonical Wnt signaling is upstream of the Hedgehog pathway
during secondary palate development.
Wnt inhibition ‘‘rescues’’ GSK-3b null embryo palates
If canonical Wnt signaling is truly upstream of the Hedgehog
pathway, treating GSK-3b null embryo palate cultures with Dkk-1,
a Wnt inhibitor, should ‘‘rescue’’ both osteogenic gene expression
and Hedgehog signaling activity in the mutant embryo. Therefore,
e13.5 palate cultures were again established. This time, however,
GSK-3b null embryos, in addition to their wild-type littermates,
were treated with DMEM F12 +/2 supplementation with Dkk-1
(100 ng/mL) for 2 days (Figure 9). We found that GSK-3b null
embryos continued to express significantly lower levels of
osteogenic gene markers (Alp, Runx2, Ocn, and Col1a1) by qRT-
PCR, when compared to their wild-type littermates (Figure 9A,
Figure 4. e15.5 GSK-3b null embryos exhibit increased canonical Wnt signaling in the developing palate. (A) Immunohistochemistry for
total b-catenin (second column), active b-catenin (third column), and Axin-2 (fourth column) in GSK-3b +/+ and GSK-3b 2/2 embryos. The first
column is included for orientation purposes. The dotted lines in the first column indicate the areas shown in higher magnification in the second,
third, and fourth columns. As shown, GSK-3b 2/2 embryos have more intense total b-catenin, active b-catenin, and Axin-2 immunostaining than
controls in the palatine bone (pb), suggesting that GSK-3b 2/2 embryos have increased canonical Wnt signaling compared to GSK-3b +/+ embryos.
Tongue (t) and nasal cavity (nc) are labeled for orientation purposes. Scale bars in the lower magnification images (first column) represent 200 mm.
Scale bars in the higher magnification images (second, third, and fourth columns) represent 100 mm. (B) Quantification of DAB-positive nuclei per
high power field, displaying significantly greater active b-catenin positive nuclei in the GSK-3b 2/2 palates when compared to controls. N=3,
*,p0.05. (C) In situ hybridization for Wnt 9b, a canonical Wnt ligand expressed in the craniofacial region. The dotted lines in the first and fourth
column indicate the area shown in higher magnification in the second and third columns, respectively. The intensity and distribution of Wnt9b
transcripts is greater in the GSK-3b 2/2 palates when compared to controls. Tongue (t) and nasal cavity (nc) are labeled for orientation purposes.
Scale bars in the lower magnification images (first and fourth column) represent 200 mm. Scale bars in the higher magnification images (second and
third columns) represent 100 mm.
doi:10.1371/journal.pone.0025847.g004
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25847Figure 5. GSK-3b null embryos display decreased Hedgehog signaling in the developing palate. (A–D) In situ hybridization and/or
immunohistochemistry of e15.5 coronal sections from GSK-3b +/+ and GSK-3b 2/2 embryos to evaluate in vivo Hedgehog signaling. For in situ
hybridizations, the signal appears purple. For immunohistochemistry, the signal is developed with DAB (brown color) and counterstained in
hematoxylin (blue). The first column is for orientation purposes. The orange box in the images in the first column represent the area shown in high
magnification in the second and third columns. (A) In situ hybridrization for the Hedgehog ligand, Ihh, demonstrating that GSK-3b 2/2 embryos have
decreased Ihh transcripts in the palatine bone when compared to controls. (B) In situ hybridization for the Hedgehog receptor, Ptch1, demonstrating
that GSK-3b 2/2 palates have decreased Ptch1 transcript in the palatine bone when compared to controls. (C) Immunohistochemistry for the
Hedgehog receptor, Ptch1, demonstrating that GSK-3b 2/2 palates have decreased Ptch1 immunostaining when compared to controls. (D)
Immunohistochemistry of the Hedgehog downstream target, Gli1, demonstrating that GSK-3b 2/2 palates have decreased Gli1 protein
immunoreactivity in the palatine bone than controls. (E) qRT-PCR of e15.5 GSK3b +/+ and 2/2 palates. The specific genes analyzed include Hedgehog
ligands, Ihh and Shh, and the Hedgehog downstream target, Gli1. GSK-3b 2/2 embryos displayed significantly decreased levels of Ihh, Shh, and Gli1,i n
comparison to controls. N=3, *p,0.01.
doi:10.1371/journal.pone.0025847.g005
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expression (Alp, Runx2, Ocn, and Col1a1) in the GSK-3b null
embryos treated with Dkk-1 resulted in non-significant differences,
when compared to their wild-type littermates treated with DMEM
F12 alone (Figure 9A, white and green bars). Additionally,
similar results were observed after performing qRT-PCR for
members of the Hedgehog signaling pathway (Figure 9B). While
GSK-3b null embryos treated with DMEM F12 alone expressed
significantly lower levels of the Hedgehog ligands, Ihh and Shh,
receptor, Ptch1, and downstream target, Gli 1, when compared to
wild-type littermates under the same conditions (Figure 9B,
white and blue bars), following treatment with Dkk-1, GSK-3b
null embryos expressed significantly higher levels of Ihh, Ptch1, and
Gli 1, when compared to wild-type littermates treated with
DMEM F12 alone (Figure 9B, white and green bars). No
significant differences were noted in expression levels of Shh
between GSK-3b +/+ embryos treated with DMEM F12 alone and
GSK-3b 2/2 embryos treated with Dkk-1 (Figure 9B, white
Figure 6. Canonical Wnt signaling activation makes wild-type palates more GSK-3b ‘‘knock-out like’’ in vitro. (A–B) e13.5 wild-type, CD-1
palate cultures were treated with DMEM F12 +/2 supplementation with Wnt3A (100 ng/mL) for 2 days. qRT-PCR was performed to evaluate both
osteogenic gene expression (A) and Hedgehog signaling activity (B). N=3, *p,0.01. (A) Wild-type palates treated with Wnt3A for 2 days exhibited
significantly decreased expression of the osteogenic genes Alp, Runx2, Ocn, and Col1a1 by qRT-PCR when compared to controls. (B) Palates treated
with Wnt3A for 2 days displayed decreased Hedgehog signaling activity, with significantly decreased levels of Ihh, Shh, and Gli1 by qRT-PCR. (C–D)
e13.5 wild-type, CD-1 palate cultures were treated with DMEM F12 +/2 supplementation with Dkk-1 (100 ng/mL) for 2 days. qRT-PCR was performed
to evaluate both osteogenic gene expression (C) and Hedgehog signaling activity (D). N=3, *p,0.01. (C) Wild-type, CD-1 palates treated for 2 days
with Dkk-1 demonstrated a significant increase in the osteogenic genes Alp, Runx2, Ocn, and Col1a1. (D) Palates treated for 2 days with Dkk-1
demonstrated significant increases in the Hedgehog ligands, Ihh and Shh and the downstream target, Gli1.
doi:10.1371/journal.pone.0025847.g006
Figure 7. Inhibition of the Hedgehog pathway leads to decreased ostegenesis in vitro. (A–B) qRT-PCR of e13.5 wild-type, CD-1 palate
cultures treated with DMEM F12 +/2 supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. N=3, *p,0.01. (A) Wild-type, CD-
1 palates treated with cyclopamine for 2 days exhibited a decrease in osteogenic markers Alp, Runx2, and Col1a1 by qRT-PCR, with a significant
decrease in Col1a1. (B) Wild-type palates treated with Shh-N exhibited significant increases in the osteogenic genes Alp, Runx2, and Col1a1.
doi:10.1371/journal.pone.0025847.g007
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hypotheses that GSK-3b null embryos display inhibited ossification
of the secondary palate, as a result of both Wnt signaling activation
and Hedgehog signaling inhibition, and additionally, that Wnt
signaling is upstream of Hedgehog signaling during secondary palate
development.
Discussion
In this study, we provide evidence for enhanced canonical Wnt
signaling in the GSK-3b null embryo in the region of the palatine
bone with simultaneous decreases in Hedgehog signaling. Impor-
tantly, our study demonstrates that inhibition of GSK-3ß leads to a
decrease in the osteogenic differentiation of palatal mesenchymal
cells, leading to the underdevelopment of the palatine bones.
Additionally, through the use of palate cultures, we found that we
can mimic the changes we observed in the GSK-3ß null palatine
bone in both osteogenic gene expression and Hedgehog signaling
activity through treatment with recombinant Wnt3A alone.
Furthermore, it appears that canonical Wnt signaling may be
upstream of Hedgehog signaling during secondary palate develop-
ment as increases or decreases in Wnt signaling resulted in
decreased or increased Hedgehog signaling activity, respectively,
while alterations in Hedgehog signaling did not appear to affect
canonical Wnt signaling. Lastly, we found that Wnt signaling
inhibition in GSK-3b null embryos was sufficient to ‘‘rescue’’ both
osteogenic gene expression and Hedgehog signaling in the mutant
embryo. Taken together, these data describe a palatal phenotype
and provide a possible mechanism behind the observation that
GSK-3ß is important for palatine bone ossification.
Several Wnt antagonists have been described including
Dickkopfs (DKKs) and Sclerostin [19,20,21]. Dkk-1 specifically
suppresses the canonical Wnt pathway by binding to the Wnt
receptor, LRP5/6 [22]. Therefore, Dkk-1 acts upstream from
GSK-3ß to inhibit canonical Wnt signaling. However, it remains
possible to inhibit ß-catenin-dependent Wnt signaling in both wild-
type and GSK-3ß null embryos. This is because two functionally
redundant isoforms of GSK-3 exist in mammals, GSK-3a and
GSK-3ß [23]. This functional redundancy allows GSK-3ß null
embryos to exhibit some GSK-3 inhibition of ß –catenin, but not
enough to fully compensate for the loss of GSK-3ß [23]. For this
reason, we were able to inhibit canonical Wnt signaling in both
wild-type and GSK-3ß null embryos.
Analysis of the canonical Wnt signaling pathway in the
developing palate has revealed that there is baseline activation in
wild-type mice. However, with deletion of the GSK-3ß gene, we
noticed a significant upregulation in canonical Wnt signaling. Our
observation that Dkk-1 stimulates an increase in osteogenic gene
expression in palate cultures leads us to believe that the precise
regulation of canonical Wnt signaling likely plays a role in palatal
mesenchyme osteogenic differentiation.
If the impaired palatal ossification seen in our GSK-3ß null
embryo is due, in part, to sustained activation of the canonical Wnt
pathway, which subsequently leads to inhibition of the Hedgehog
Figure 8. Canonical Wnt signaling is similar in both Ihh +/+ and Ihh 2/2 embryos. (A) Immunohistochemistry for b-catenin, active b-catenin,
and Axin-2 in e15.5 coronal sections from Ihh +/+ and Ihh 2/2 embryos. Little to no difference is appreciated between Ihh +/+ and Ihh 2/2 embryos.
For orientation, the first column shows a low magnification image with dotted lines around the area shown in high magnification in the second, third,
and fourth columns. Tongue (t) and nasal cavity (nc) are labeled for orientation purposes. Scale bars in the lower magnification images (first column)
represent 200 mm. Scale bars in the higher magnification images (second, third, and fourth columns) represent 100 mm. (B) Quantification of DAB-
positive nuclei per high power field demonstrating no significant differences in active b-catenin immunostaining between Ihh +/+ and 2/2 palates.
N=3, *p,0.05. (C) In situ hybridization of Wnt 9b, a canonical Wnt ligand expressed in the craniofacial region. Similarly, no difference in the domain or
intensity of Wnt9b transcripts is noted between groups. Scale bars in the lower magnification images (first and fourth column) represent 200 mm.
Scale bars in the higher magnification images (second and third columns) represent 100 mm.
doi:10.1371/journal.pone.0025847.g008
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palate cultures would lead to similar decreases in osteogenic
differentiation and Hedgehog signaling activity as observed in GSK-
3b 2/2palates. Conversely, supplementation with the canonical
Wnt inhibitor, Dkk-1, should enhance osteogenic gene expression
and Hedgehog signaling activity. In our organ culture assay, we
found these results indeed to be the case. Taken together, these
data confirm that the impaired ossification of the secondary palate
is due, at least in part, to enhanced canonical Wnt signaling in
GSK-3ß null embryos.
Similarly, if decreases in the Hedgehog pathway alone also
contribute, in part, to the impaired palatal ossification observed in
GSK-3ß null embryos, we would expect palate cultures treated with
the Hedgehog inhibitor, cyclopamine, to display decreases in
osteogenic gene expression. Conversely, palate cultures treated
with the Hedgehog agonist, Shh-N, should result in increases in
osteogenic gene expression. We found this again to be the case,
confirming that the decreased palatal mesenchymal osteogenesis
observed in the GSK-3ß null embryo is also due, in part, to
decreases in Hedgehog signaling.
The increase in canonical Wnt signaling that coincides with a
decrease in Hedgehog signaling observed in GSK-3b null embryos
suggests that there may be a coordination between these two
pathways in palatal mesenchymal cell osteogenesis. Previous
studies have shown that increases in canonical Wnt [12] or
decreases in Hedgehog signaling [11] result in inhibited ossification.
In light of these previous studies, our results suggest that increases
in Wnt signaling, such as those observed in the GSK-3ß null
embryo, act to inhibit the ossification program already in place.
Furthermore, the inhibition of Hedgehog signaling likely serves to
only further inhibit palatal ossification. Therefore, while aberra-
tions in either the Wnt and Hedgehog pathway alone could explain
the impaired palatal ossification found in GSK-3ß null embryos, it
seems likely that both increased Wnt signaling and decreased
Hedgehog signaling contribute to the palatal phenotype observed in
these mutant embryos.
Figure 9. Wnt signaling inhibition ‘‘rescues’’ GSK-3b null embryo osteogenic gene expression and Hedgehog signaling activity. (A–B)
e13.5 GSK-3b +/+ and 2/2 embryo palate cultures treated for 2 days with DMEM F12 +/2 supplementation with Dkk-1 (100 ng/mL). (A) qRT-PCR for
the osteogenic gene markers Alp, Runx2, Ocn, and Col1a1.N=3 ,* ,0.01. (B) qRT-PCR for members of the Hedgehog signaling pathway (Ihh, Shh, Ptch1,
and Gli1). N=3, *,0.01.
doi:10.1371/journal.pone.0025847.g009
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non-canonical Wnt signaling pathway may also play a role in the
palatal ossification process [24]. While Wnt-3A was previously
believed to specifically upregulate the canonical Wnt pathway
alone [25,26], Nalesso et al. found that treatment of articular
chondrocytes with Wnt-3A led to an upregulation of both
canonical, ß-catenin-dependent, and non-canonical, CaMKII-
dependent, signaling. Additionally, they found these two pathways
to be reciprocally inhibitory [24]. While their study was performed
to evaluate chondrogenesis of articular chondrocytes rather than
osteogenesis of palatal mesenchyme, future studies on how the
non-canonical, CaMKII-dependent pathway affects the palatal
ossification process may shed further light on our findings.
In summary, based on our findings, we propose that GSK-3ß
inhibition leads to canonical Wnt signaling activation and
subsequent decreases in Hedgehog signaling. Both the enhanced
canonical Wnt signaling and decreased Hedgehog signaling contrib-
ute to the impaired palatal osteogenesis observed in the GSK-3ß
null embryos. In addition, because alterations in the canonical Wnt
pathway led to aberrant Hedgehog signaling, while alterations in
Hedgehog signaling led to no obvious changes in the canonical Wnt
pathway, it seems likely that canonical Wnt functions upstream of
Hedgehog signaling during secondary palate development. More-
over, the fact that we were able to ‘‘rescue’’ both osteogenic gene
expression and Hedgehog signaling activity in the GSK-3b 2/2
palates with a Wnt inhibitor provides even stronger evidence for
the above stated hypotheses.
Craniofacial clefts, and specifically, clefting of the secondary
osseous palate remain a significant biomedical burden. Therefore,
understanding the pathways behind secondary palate formation
may allow us to better develop therapeutic modalities to treat these
patients.
Materials and Methods
Ethics Statement
All efforts were made to ameliorate suffering of animals.
Animals were housed in the Research Animal Facility on Stanford
University campus. The facility, accessed by authorized personnel
only, is temperature, ventilation and illumination controlled. Mice
have access to feed and water ad libitum. All mice housing conforms
to NIH Guide standards, the Animal Welfare Act, and ILAR guide.
Transportation of animals was performed based on the ‘‘Guide-
lines for Transportation of Animals from the Stanford Centralized
Animal Facilities,’’ developed by the Administrative Panel on
Laboratory Animal Care (A-PLAC). All animal procedures were
approved by Stanford A-PLAC, Protocol #9999. No cell lines
were used.
Animals
The transgenic mouse lines for GSK-3ß were a gift from J.
Woodgett and have been described previously [1,27]. All of the
experiments shown on GSK-3b 2/2 embryos were performed in
outbred CD-1 mice; however, we found the same cleft palate
phenotype in the original GSK-3ß 2/2 mice. Ihh +/2 mice were
mated to generate Ihh 2/2 embryos on a C57B6 background. Ihh
+/2 mice were mated to obtain both Ihh +/+ and Ihh 2/2 mice
[11]. For all experiments, animals were bred over night and the
day of vaginal plug was considered to be e0.5 days of gestation.
Palatal shelf dissection
Wild-type, GSK-3ß +/+ and GSK-3ß2/2 embryos were
harvested at e13.5 of gestation and immediately placed on ice
in cold, sterile, phosphate-buffered saline. Microdissection was
performed on the individual embryos to isolate and remove the
palatal shelves. Palatal shelves were transferred onto 0.4-mm
pore-size filter inserts (Falcon cell culture insert; Becton
Dickinson, Franklin Lakes, N.J.) and placed in organ culture
plates (Corning Inc., Corning, N.Y.). In vivo orientation was
maintained throughout. Palatal shelves were cultured with the
paired shelves in parallel with the medial edge epithelium of each
palate facing each other with the nasal side down onto the filter
inserts. Filter inserts were suspended on top of wells containing
Dulbecco minimal essential medium/Ham’s F12 growth medium
supplemented with 300 mg/ml l-glutamate, 50 mg/ml glycine,
100 mg/ml ascorbate, 1% penicillin/streptomycin (all from
Gibco, Grand Island, N.Y.) at 37uC in a 5% CO2 environment
[28]. Palate cultures were then treated with the above +/2
mouse recombinant Sonic Hedgehog/Shh, N terminus (250 ng/
mL), recombinant mouse Wnt3A (100 ng/mL), recombinant
mouse Dkk-1 (100 ng/mL), or Cyclopamine (20 mM) (R&D
systems, Minneapolis, MN). Specimens were examined micro-
scopically 4 hours after initial placement of the paired palatal
shelves into culture, to determine whether any premature
migration or change in orientation of shelves had occurred
requiring readjustment to the originally recorded separation
distance and alignment. Palates were harvested after 48 hours
and RNA was isolated immediately. In addition, e15.5 GSK-3b
+/+ and 2/2 palates were dissected and immediately snap
frozen for later RNA isolation.
RNA Isolation and Real-Time PCR
Once removed from culture, palates were pooled (N=3 distinct
pooled samples, consisting of 2 microdissected palates per sample),
and homogenized by sonification. RNA was isolated per the
manufacturer’s instructions (RNeasy Kit, Qiagen Sciences, Mary-
land), genomic DNA was removed (DNA-free kit, Ambion, Austin,
TX), and a total of 1 ug RNA was reverse-transcribed (Taqman
Reverse Transcription Reagents, Applied Biosystems, Foster City,
CA). Quantitative real-time PCR was carried out using the Applied
Biosystems Prism 7900HT Sequence Detection System and Power
Sybr Green Mastermix (Applied Biosystems, Foster City, CA).
Specific primers were designed based on PrimerBank sequences
(http://pga.mgh.harvard.edu/primerbank/). Sequences are shown
in Table 1. All reactions were performed in triplicate; relative
values were calculated to housekeeping gene (GAPDH)a n d
presented as means and standard deviations.
Tissue Processing and Histology
For histological analysis, sections were prepared from tissues
fixed overnight in 0.4% PFA, decalcified in 19% EDTA (pH 7.4)
at 4uC and dehydrated through graded ethanol for paraffin
embedding. For histological staining, 5 mm paraffin-embedded
tissue sections were stained with Movat’s Pentachrome bone stain.
Immunohistochemistry was performed on select slides for b-
catenin, Ptch1, and Gli1 (Santa Cruz Laboratories, Santa Cruz,
CA), in addition to active b-catenin (Millipore, Billerica, MA) and
Axin 2 (Abcam, Cambridge, MA). Slides were deparaffinized and
rehydrated. Endogenous peroxidase activity was quenched with
3% hydrogen peroxide in methanol. Antibodies used included
rabbit polyclonal anti-b-catenin, (1:50 in dilution, Santa Cruz
Laboratories, Santa Cruz, CA), rabbit polyclonal anti-Ptch1 (1:50
in dilution, Santa Cruz Laboratories, Santa Cruz, CA), rabbit
polyclonal anti-Gli1 (1:80 in dilution, Santa Cruz Laboratories,
Santa Cruz, CA), mouse monoclonal anti-active b-catenin (1:50 in
dilution, Millipore, Billerica, MA), and rabbit polyclonal anti-
Axin-2 (1:400 dilution, Abcam, Cambridge, MA). Rabbit
polyclonal antibodies were blocked in 5% goat serum (Vector
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blocked in 5% horse serum (Vector Laboratories, Burlingame,
CA). Appropriate biotinylated secondary antibodies were used in
1:1000 dilution (Vector Laboratories, Burlingame, CA). The
Vectastain ABC system (Vector Laboratories, Burlingame, CA)
was used according to the manufacturer’s instructions. Visualiza-
tion was with diaminobenzidine solution (Zymed Laboratories,
South San Francisco, CA). Slides without primary antibody were
used as a negative control. No less than 5 slides were stained for
each antibody per animal (N=3).
Quantification of active b-catenin positive nuclei amongst GSK-
3b and Ihh +/+ and 2/2 embryos was performed using the
Count Tool on Adobe Photoshop. Photographs of active b-catenin
immunostaining on coronoal sections were taken at 406
magnification (3 animals per group, 5 slides per animal). The
number of brown stained nuclei were counted by a single blinded
investigator, and confirmed by a second, independent investigator.
In situ hybridization was performed on select slides for mouse
Runx2, Ocn, Col1a1, Ihh, and Ptc1 as previously described [29].
Briefly, the template was amplified from embryonic mouse cDNA
by PCR using sequence-specific primers that included either the
T7 or T3 RNA promoter region to make both anti-sense and sense
probes, respectively. Anti-sense and sense riboprobe was tran-
scribed with T7 RNA polymerase and T3 RNA polymerase,
respectively, in the presence of Dig-11-UTP (Roche). Sections
were incubated at 63uC for 12 hrs in hybridization buffer
(Ambion, Austin TX) containing riboprobe at ,1 ug/mL probe.
Slides were blocked with 10% lamb serum (Invitrogen, Carlsbad,
CA), 1% Boehringer-Mannheim Blocking Reagent (Roche), and
levamisole, and developed using NBT and BCIP for color. Non-
specific binding was minimized by high stringency hybridization
conditions. For all assays, sense probes were used side-by-side with
minimal background.
Whole mount skull preparation
To evaluate the palate phenotype of wild-type, GSK-3ß2/+ and
GSK-3ß2/2 embryos, whole mount bone and cartilage staining
was performed as previously described [29]. Specimens were fixed
in 100% ethanol for 48 h, transferred to acetone for 48 h, stained
in 0.15% alcian blue in 20% glacial acetic/80% ethanol for 24 h,
fixed in ethanol for 24 h and cleared in 1% aqueous KOH for 24–
31 h prior to staining in 0.005% alizarin red in 1% KOH for 15 h.
The tissue was cleared through 20% glycerol 1% KOH for 24–
72 h, followed by increasing concentrations of glycerol in dH2O
up to 70%.
Palatine bone area was quantified using the Lasso Tool on
Adobe Photoshop. Photographs were taken of the palatine bones
at 46magnification. The absolute number of pixels was quantified
using Adobe Photoshop. N=3 animals per group.
Statistical analyses
Means and standard deviations were calculated from all
numerical data. In graphs, all bars represent means whereas all
error bars represent one standard deviation. Statistical analyses
were performed using the Welch’s two-tailed t-test when
comparing two groups with unequal standard deviations.
*P,0.01 was considered significant, unless otherwise stated.
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